SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
SciClone Pharmaceuticals (Holdings) Limited, in conjunction with Silver Pegasus Investment Limited, has announced a proposal for privatization through a scheme of arrangement, with the intention to also withdraw its listing from the stock exchange. The proposal has been sanctioned by the Grand Court and is pending the fulfillment or waiver of certain conditions as stipulated in their Scheme Document. This strategic move is poised to reshape the company’s financial and operational framework.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.